COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
HCQ study #175 of 237
11/5 Late treatment study
Maldonado et al., NefrologĂ­a, doi:10.1016/j.nefro.2020.09.002 (Peer Reviewed)
COVID-19 incidence and outcomes in a home dialysis unit in Madrid (Spain) at the height of the pandemic
Source   PDF   Share   Tweet
Small retrospective 12 dialysis patients, 1/11 deaths with HCQ and 1/1 without HCQ.

Maldonado et al., 11/5/2020, retrospective, Spain, Europe, peer-reviewed, 10 authors.
risk of death, 90.9% lower, RR 0.09, p = 0.17, treatment 1 of 11 (9.1%), control 1 of 1 (100.0%).
Details of all 237 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit